We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Andrew Tauber Mayer Brown LLP

Results 1 to 5 of 20



US Supreme Court grants certiorari in three cases affecting employers *

USA - June 27 2012
As the Supreme Court looks ahead to its next term, the Court granted certiorari in three cases of particular significance to employers.

Co-authors: Dan Himmelfarb, Kevin S. Ranlett, Evan M. Tager .


US Supreme Court issues opinion in Southern Union Co. v. United States *

USA - June 22 2012
In Apprendi v. New Jersey, 530 U.S. 466 (2000), the Supreme Court held that under the Sixth Amendment “any fact,” other than the fact of a prior conviction, that increases the penalty for a crime beyond the prescribed statutory maximum “must be submitted to a jury, and proved beyond a reasonable doubt.” Id. at 490.

Co-authors: Dan Himmelfarb.


US Supreme Court issues opinion in Christopher v. Smithkline Beecham Corp. *

USA - June 18 2012
The outside-sales exemption of the Fair Labor Standards Act (“FLSA”) provides that an individual who is employed “in the capacity of outside salesman” is not entitled to overtime pay.

Co-authors: Dan Himmelfarb.


US Supreme Court issues opinion in Kappos v. Hyatt *

USA - April 19 2012
When the United States Patent and Trademark Office (“PTO”) denies an application for a patent, the applicant may seek judicial relief in two different ways.


Fourth Circuit rules that federal law preempts state-law claims arising from alleged malfunction of medical device that complied with FDA requirements *

USA - February 1 2012
In Walker v. Medtronic, Inc., No. 10-2219, ___F.3d___ (January 25, 2012), the US Court of Appeals for the Fourth Circuit held that the Medical Device Amendments to the Food, Drug, and Cosmetic Act preempt state-law claims arising from the alleged malfunction of a Class-III medical device that had received premarket approval from the Food and Drug Administration and had complied with all requirements imposed by the agency.

Co-authors: Daniel L. Ring.


Next »